Reversible Hepatotoxicity to IL-1/IL-6 Blockade in Pediatric Patients with Systemic Juvenile Idiopathic Arthritis and Macrophage Activation Syndrome

被引：0
|
作者：
Phadke, Omkar
Prahalad, Sampath
Rouster-Stevens, Kelly
机构：
来源：
ARTHRITIS & RHEUMATOLOGY | 2020年 / 72卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
099
引用
收藏
页码：175 / 176
页数：2
相关论文
共 50 条
  • [1] Rescue Treatment by Increased Doses of IL-1 Inhibitors for Macrophage Activation Syndrome in Children With Systemic Juvenile Idiopathic Arthritis
    Kostik, Mikhail
    Snegireva, Ludmila
    Dubko, Margarita
    Masalova, Vera
    Likhacheva, Tatyana
    Kornishina, Tatyana
    Chikova, Irina
    Buchinskaya, Natalia
    Kalashnikova, Olga
    Chasnyk, Vyacheslav
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S133 - S133
  • [2] IL-1 Inhibition in Systemic Juvenile Idiopathic Arthritis
    Giancane, Gabriella
    Minoia, Francesca
    Davi, Sergio
    Bracciolini, Giulia
    Consolaro, Alessandro
    Ravelli, Angelo
    FRONTIERS IN PHARMACOLOGY, 2016, 7
  • [3] Eosinophilia and Exposure to IL-1 and IL-6 Blocking Biologic Medications in a Systemic Juvenile Idiopathic Arthritis Patient Cohort
    Dickey, Rachel
    Dhar, Doel
    Gangireddy, Srushti
    Ong, Henry H.
    Wei, Wei-Qi
    Patrick, Anna
    ARTHRITIS & RHEUMATOLOGY, 2024, 76 : 793 - 794
  • [4] IL-6 blockers in systemic onset juvenile idiopathic arthritis
    Barone, Patrizia
    Pignataro, Rossana
    Garozzo, Maria Teresa
    Leonardi, Salvatore
    IMMUNOTHERAPY, 2016, 8 (01) : 79 - 87
  • [5] Incidence, Risk Factors, and Outcomes of Eosinophilia on IL-1 and IL-6 Inhibitors in Systemic and Non-Systemic Juvenile Idiopathic Arthritis
    Wobma, Holly
    Taylor, Maria
    Lam, Ki Pui
    Brown, Helene
    Case, Siobhan
    Chandler, Mia
    Chang, Margaret
    Cohen, Ezra
    Day-Lewis, Megan
    Halyabar, Olha
    Hausmann, Jonathan
    Hazen, Melissa
    Janssen, Erin
    Lee, Pui
    Lo, Mindy
    Meidan, Esra
    Roberts, Jordan
    Son, Mary Beth F.
    Sundel, Robert
    Dedeoglu, Fatma
    Nigrovic, Peter
    Casey, Alicia
    Chang, Joyce
    henderson, lauren
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 1721 - 1723
  • [6] Role of interleukin-1 (IL-1) in the pathogenesis of systemic onset juvenile idiopathic arthritis and clinical response to IL-1 blockade
    Pascual, V
    Allantaz, F
    Arce, E
    Punaro, M
    Banchereau, J
    JOURNAL OF EXPERIMENTAL MEDICINE, 2005, 201 (09) : 1479 - 1486
  • [7] IL-18 as a biomarker linking systemic juvenile idiopathic arthritis and macrophage activation syndrome
    Yasin, Shima
    Fall, Ndate
    Brown, Rachel A.
    Henderlight, Maggie
    Canna, Scott W.
    Girard-Guyonvarc'h, Charlotte
    Gabay, Cem
    Grom, Alexei A.
    Schulert, Grant S.
    RHEUMATOLOGY, 2020, 59 (02) : 361 - 366
  • [8] Dramatic clinical response to IL-1 blockade in systemic onset juvenile idiopathic arthritis.
    Pascual, V
    Allantaz, F
    Arce, E
    Stichweh, D
    Connolly, J
    Punaro, M
    Banchereau, J
    ARTHRITIS AND RHEUMATISM, 2004, 50 (12): : 4099 - 4100
  • [9] In-vitro Influence of TNF-α, IL-1 and IL-6 Antagonists (Biologicals) of the Cytokine Network in Patients with systemic juvenile idiopathic Arthritis (sJIA)
    Robinson, B.
    Kirchner, M.
    Sonnenschein, A.
    Mannhardt-Laakmann, W.
    ZEITSCHRIFT FUR RHEUMATOLOGIE, 2013, 72 : 95 - 95
  • [10] THE USE OF A COMBINATION OF IL-1 AND IL-6 INHIBITION IN THE MANAGEMENT OF SEVERE, AGGRESSIVE, EROSIVE, SYSTEMIC-ONSET JUVENILE IDIOPATHIC ARTHRITIS
    Lee, Martin
    Nicholl, Karl
    Campbell, Ian
    RHEUMATOLOGY, 2016, 55 : 157 - 157
12345